<DOC>
	<DOCNO>NCT02554279</DOCNO>
	<brief_summary>The purpose trial demonstrate non-inferiority MENOPUR® versus recombinant Follicle Stimulating Hormone ( rFSH ) ( Gonal-f® ) respect ongoing pregnancy rate woman undergo controlled ovarian stimulation ( COS ) follow GnRH treatment .</brief_summary>
	<brief_title>MENOPUR® Gonadotropin-Releasing Hormone ( GnRH ) Antagonist Cycle With Single-Blastocyst Transfer High Responder Subject Population</brief_title>
	<detailed_description />
	<mesh_term>Infertility</mesh_term>
	<mesh_term>Hormones</mesh_term>
	<mesh_term>Follicle Stimulating Hormone</mesh_term>
	<mesh_term>Menotropins</mesh_term>
	<criteria>Females age 21 35 year regular ovulatory menstrual cycle 21 45 day , Body Mass Index ( BMI ) 18 30 kg/m2 desire pregnancy . Subjects must high responder , define subject serum antiMüllerian hormone ( AMH ) ≥5 ng/mL screening . Documented history infertility ( e.g. , unable conceive least 12 month least 6 month receive donor sperm ) Day 2 Day 3 serum FSH level 1 12 IU/L ( inclusive ) , result obtain within 6 month prior randomization . Known stage IIIIV endometriosis ( American Society Reproductive Medicine , 2012 ) . History recurrent miscarriage follow live birth ( recurrent define two ( 2 ) consecutive miscarriage ) . Previous vitro fertilization ( IVF ) assist reproductive technology ( ART ) failure due poor response gonadotropin . Poor response define development ≤2 mature follicles history 2 previous fail cycle cancellation prior oocytes retrieval due poor response .</criteria>
	<gender>Female</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>